Rinvoq ER 30 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FQ77Z
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,581
Award facts
- Contract value 100% obligated
- $11,581.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,581.02 to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of RINVOQ ER 30 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 18, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. RINVOQ is a Janus kinase inhibitor used primarily for treating rheumatoid arthritis and other inflammatory conditions, reflecting the Department of Defense's ongoing pharmaceutical procurement needs for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement extending through December 2026 that enables comprehensive global pharmaceutical support to military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, regularly fulfills such delivery orders on a competitive basis across diverse therapeutic domains including specialty medications, generic and brand-name drugs, and medical supplies supporting the Defense Health Agency and other federal healthcare entities.
Quick answers
Who was awarded contract SPE2DB25FQ77Z?
SPE2DB25FQ77Z was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FQ77Z worth?
The government has obligated $11,581 on SPE2DB25FQ77Z.
Is contract SPE2DB25FQ77Z an order under another contract?
Yes. SPE2DB25FQ77Z is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FQ77Z competed?
The extent of competition for SPE2DB25FQ77Z was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award